Canine leishmaniasis: Update on epidemiology, diagnosis, treatment, and prevention

M Morales-Yuste, J Martín-Sánchez… - Veterinary Sciences, 2022 - mdpi.com
Simple Summary Dogs are the main host of Leishmania infantum, a parasite that causes an
incurable disease called canine leishmaniasis. This parasite is transmitted through the bite …

Drug-dosing adjustment in dogs and cats with chronic kidney disease

F De Santis, A Boari, F Dondi, PE Crisi - Animals, 2022 - mdpi.com
Simple Summary Adjusting drug dosages in dogs and cats with chronic kidney disease
(CKD) can be challenging in clinical practice due to the lack of specific indications in the …

Effective immuno-therapeutic treatment of Canine Leishmaniasis

RAN Ramos, A Giannelli, F Fasquelle… - PLoS Neglected …, 2023 - journals.plos.org
Background Canine Leishmaniasis (CanL) caused by the L. infantum species is one of the
biggest threats to the health of the South American canine population. Chemotherapeutics …

[HTML][HTML] Treatment of canine leishmaniasis with meglumine antimoniate: a clinical study of tolerability and efficacy

S Digiaro, A Recchia, A Colella, S Cucciniello, B Greco… - Animals, 2024 - mdpi.com
Simple Summary This study evaluates the potential adverse effects associated with
meglumine antimoniate (aNm) in the treatment of canine leishmaniasis through both a …

Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis

ECBS Ayres, ÁFLR Dias, BRG Monteiro… - Revista Brasileira de …, 2022 - SciELO Brasil
Canine visceral leishmaniasis is an endemic zoonosis in Brazil. Dogs are the main hosts in
urban environments. The treatment has gained popularity since the Brazilian government …

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis

M Gizzarelli, V Foglia Manzillo, A Inglese… - Pathogens, 2023 - mdpi.com
Miltefosine-Allopurinol (MIL-AL) combination is reported to be one of the most effective
treatments for canine leishmaniosis, thanks to its oral administration and MIL-documented …

Relapses in canine leishmaniosis: risk factors identified through mixed-effects logistic regression

J Sarquis, LM Raposo, CR Sanz, A Montoya… - Parasites & …, 2024 - Springer
Abstract Background Canine leishmaniosis (CanL), caused by Leishmania infantum, is an
important vector-borne parasitic disease in dogs with implications for human health. Despite …

[HTML][HTML] Short Term Treatment Monitoring of Renal and Inflammatory Biomarkers with Naturally Occurring Leishmaniosis: A Cohort Study of 30 Dogs

V Pantaleo, T Furlanello, M Campigli, L Ventura… - Veterinary …, 2024 - mdpi.com
Various inflammatory and renal biomarkers have already been assessed for monitoring the
response to anti-leishmanial therapy in canine leishmaniosis. This study assessed the …

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

AI Olías-Molero, P Botías, M Cuquerella… - Antibiotics, 2023 - mdpi.com
Visceral leishmaniasis (VL), a vector-borne parasitic disease caused by Leishmania
donovani and L. infantum (Kinetoplastida), affects humans and dogs, being fatal unless …

Retrospective study on the outcome of treatment with miltefosine for canine Leishmaniasis in veterinary first-line practice.

Z Feenstra - 2023 - studenttheses.uu.nl
Canine Leishmaniasis is a vector-borne disease caused by the intracellular protozoa
Leishmania infantum, which continues to be a difficult and challenging disease to effectively …